CSPC Pharmaceutical Group's revenue for the
three
months ended in Dec. 2023 was HK$8,296 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$34,600 Mil.
CSPC Pharmaceutical Group's Revenue per Share for the
three
months ended in Dec. 2023 was HK$0.70.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2.91.
Warning Sign:
CSPC Pharmaceutical Group Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of CSPC Pharmaceutical Group was -0.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 15.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average Revenue per Share Growth Rate was 49.30% per year. The lowest was -50.00% per year. And the median was 17.50% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CSPC Pharmaceutical Group's Revenue
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Revenue distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Revenue falls into.
CSPC Pharmaceutical Group Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$34,600 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (HKSE:01093) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
CSPC Pharmaceutical Group Revenue Related Terms
Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
CSPC Pharmaceutical Group (HKSE:01093) Business Description
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01093 has been successfully added to your 